RSV cases are on the rise at St. Louis area hospitals. Both positivity rates and hospitalizations for Respiratory Syncytial Virus (RSV) are increasing.
On Tuesday, Pfizer announced promising data about its recent trials for the first maternal RSV vaccine. One of those clinical studies happened in St. Louis.
Doctors know COVID is here to stay and we have the necessary resources to fight it now. This is why they're using this time to focus on other public health issues.